Free Trial

GeneDx (WGS) Earnings Date, Estimates & Call Transcripts

GeneDx logo
$78.71 +6.64 (+9.21%)
(As of 11/22/2024 ET)

GeneDx Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 18Estimated
Actual EPS
(Oct. 29)
$0.04 Beat By $0.25
Consensus EPS
(Oct. 29)
-$0.21

GeneDx posted Q3 2024 earnings on October 29, 2024, reporting an EPS of $0.04, which beat analysts' consensus estimates of -$0.21 by $0.25. Quarterly revenue rose 44.3% year-over-year to $76.90 million, above the consensus estimate of $64.98 million. With a trailing EPS of -$3.11, GeneDx's earnings are expected to grow next year, from ($0.24) to $0.52 per share.

WGS Upcoming Earnings

GeneDx's next earnings date is estimated for Tuesday, February 18, 2025, based off prior year's reporting schedules.

Get GeneDx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

WGS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WGS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GeneDx Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.03-$0.03-$0.03
Q2 20241-$0.04-$0.04-$0.04
Q3 20241-$0.04-$0.04-$0.04
Q4 20241-$0.04-$0.04-$0.04
FY 20244($0.15)($0.15)($0.15)

GeneDx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/18/2025
(Estimated)
------- 
10/29/2024Q3 2024-$0.21$0.04+$0.25$0.39$64.98M$76.90M        
7/30/2024Q2 2024-$0.26-$0.11+$0.15$0.88$58.90M$70.51M    
4/29/2024Q1 2024-$0.68-$0.33+$0.35$0.12$49.80M$62.42M    
2/20/2024Q4 2023-$0.60-$0.59+$0.01-$0.26$57.00M$57.42M    
10/30/2023Q3 2023-$1.18-$0.82+$0.36-$53.80M$53.30M    
8/8/2023Q2 2023-$1.47-$1.65 -$0.18-$1.46$45.60M$48.71M    
5/9/2023Q1 2023-$1.65-$2.82 -$1.17-$2.60$37.90M$43.14M    

GeneDx Earnings - Frequently Asked Questions

GeneDx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates. Learn more on WGS's earnings history.

GeneDx issued an update on its FY 2024 earnings guidance on Tuesday, October, 29th. The company issued revenue guidance of $284.0 million-$290.0 million, compared to the consensus revenue estimate of $263.4 million.

In the previous quarter, GeneDx (NASDAQ:WGS) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.25. Learn more on analysts' earnings estimate vs. WGS's actual earnings.

The conference call for GeneDx's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for GeneDx's latest earnings report can be read online.
Read Transcript

GeneDx (NASDAQ:WGS) has a recorded annual revenue of $202.57 million.

GeneDx (NASDAQ:WGS) has a recorded net income of -$175.77 million. WGS has generated -$3.11 earnings per share over the last four quarters.

GeneDx's earnings are expected to grow from ($0.24) per share to $0.52 per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:WGS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners